The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research

The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research

Abstract BACKGROUND In the asymptomatic “preclinical” phase of Alzheimer's disease (AD), abnormal biomarkers indicate risk for developing cognitive impairment. Biomarker information is increasingly being disclosed to participants in research settings, and biomarker testing and results disclosur...

Full description

Bibliographic Details
Main Authors: Fred B. Ketchum, Nathaniel A. Chin, Claire Erickson, Nickolas H. Lambrou, Kristin Basche, Carey E. Gleason, Lindsay Clark
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Alzheimer's disease
biomarkers
disclosure
ethics
preclinical diagnosis
Online Access:https://doi.org/10.1002/trc2.12416

Internet

https://doi.org/10.1002/trc2.12416

Similar Items